Cartesian Therapeutics, Inc. Increase (Decrease) in Accounts Receivable
Cartesian Therapeutics, Inc. (RNAC) reported Increase (Decrease) in Accounts Receivable of -$919.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- Cartesian Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$65.00K.
- Cartesian Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$854.00K, a 195.63% decline year-over-year.
- Cartesian Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $393.00K.
- Cartesian Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $368.00K.
- Cartesian Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $243.00K.
- Cartesian Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$5.00M.
- Cartesian Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$726.00K.
- Cartesian Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$3.32M, a 223.35% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$919.00K 10-Q · filed 2026-08-06 | -$526.00K derived: sum of 3 quarters · filed 2026-08-06 | -$158.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$854.00K 10-Q · filed 2026-04-30 | -$461.00K derived: sum of 2 quarters · filed 2026-04-30 | -$93.00K derived: sum of 3 quarters · filed 2026-04-30 | -$1.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $761.00K derived: sum of 2 quarters · filed 2026-03-09 | -$650.00K derived: sum of 3 quarters · filed 2026-08-06 | $243.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $368.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.04M derived: sum of 2 quarters · filed 2026-08-06 | -$150.00K 10-Q · filed 2025-11-06 | -$4.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$518.00K 10-Q · filed 2026-08-06 | -$4.47M derived: sum of 3 quarters · filed 2026-08-06 | -$31.68M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $893.00K 10-Q · filed 2026-04-30 | -$3.06M derived: sum of 2 quarters · filed 2026-04-30 | -$30.27M derived: sum of 3 quarters · filed 2026-04-30 | -$241.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$31.17M derived: sum of 2 quarters · filed 2026-03-09 | -$1.13M derived: sum of 3 quarters · filed 2026-03-09 | -$5.00M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$27.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.82M derived: sum of 2 quarters · filed 2025-11-06 | -$1.04M 10-Q · filed 2025-11-06 | -$69.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $30.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $26.17M 10-Q · filed 2025-08-07 | $27.14M derived: sum of 3 quarters · filed 2025-08-07 | $26.65M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$3.86M 10-Q · filed 2025-05-08 | -$2.89M derived: sum of 2 quarters · filed 2025-05-08 | -$3.38M derived: sum of 3 quarters · filed 2025-05-08 | -$4.83M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $972.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $485.00K derived: sum of 2 quarters · filed 2025-03-13 | -$969.00K derived: sum of 3 quarters · filed 2025-03-13 | -$726.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | -$487.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.94M derived: sum of 2 quarters · filed 2024-11-07 | -$1.70M 10-Q · filed 2024-11-07 | -$2.03M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.21M 10-Q · filed 2024-08-08 | -$1.54M derived: sum of 3 quarters · filed 2024-08-08 | -$18.61M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $243.00K 10-Q · filed 2024-05-08 | -$86.00K derived: sum of 2 quarters · filed 2024-05-08 | -$17.16M derived: sum of 3 quarters · filed 2024-05-08 | -$314.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$329.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$17.40M derived: sum of 2 quarters · filed 2024-03-07 | -$557.00K derived: sum of 3 quarters · filed 2024-03-07 | -$3.32M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$17.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$228.00K derived: sum of 2 quarters · filed 2023-11-13 | -$2.99M 10-Q · filed 2023-11-13 | -$399.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $16.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-17 | $14.08M 10-Q · filed 2023-08-17 | $16.67M derived: sum of 3 quarters · filed 2024-03-07 | $15.53M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | -$2.76M 10-Q · filed 2023-05-04 | -$171.00K derived: sum of 2 quarters · filed 2024-03-07 | -$1.31M derived: sum of 3 quarters · filed 2024-03-07 | -$1.19M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.45M derived: sum of 2 quarters · filed 2024-03-07 | $1.57M derived: sum of 3 quarters · filed 2024-03-07 | $2.69M 10-K · filed 2024-03-07 |
| 2021-09-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$1.02M derived: sum of 2 quarters · filed 2022-11-03 | $100.00K 10-Q · filed 2022-11-03 | -$5.30M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.24M 10-Q · filed 2022-08-08 | -$4.16M derived: sum of 3 quarters · filed 2023-03-02 | $8.46M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $1.12M 10-Q · filed 2022-05-05 | -$4.28M derived: sum of 2 quarters · filed 2023-03-02 | $8.34M derived: sum of 3 quarters · filed 2023-03-02 | $8.34M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | -$5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $7.22M derived: sum of 2 quarters · filed 2023-03-02 | $7.22M derived: sum of 3 quarters · filed 2023-03-02 | $2.22M 10-K · filed 2023-03-02 |
| 2020-09-30 | $12.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $12.63M derived: sum of 2 quarters · filed 2021-11-09 | $7.63M 10-Q · filed 2021-11-09 | $12.63M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$5.00M 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-03-10 | $0.00 derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | -$5.00M 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-03-10 | $0.00 derived: sum of 3 quarters · filed 2022-03-10 | $0.00 derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $5.00M derived: sum of 2 quarters · filed 2022-03-10 | $5.00M derived: sum of 3 quarters · filed 2022-03-10 | $5.00M 10-K · filed 2022-03-10 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $0.00 derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $11.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $11.00K derived: sum of 3 quarters · filed 2021-03-12 | $0.00 10-K · filed 2021-03-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $11.00K derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | $63.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | $63.00K derived: sum of 3 quarters · filed 2020-03-12 | $63.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$11.00K 10-Q · filed 2019-05-09 | $52.00K derived: sum of 2 quarters · filed 2020-03-12 | $52.00K derived: sum of 3 quarters · filed 2020-03-12 | -$11.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $63.00K derived: sum of 2 quarters · filed 2020-03-12 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | -$152.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$63.00K derived: sum of 2 quarters · filed 2018-11-08 | -$215.00K 10-Q · filed 2018-11-08 | -$484.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$215.00K 10-Q · filed 2018-08-08 | -$484.00K derived: sum of 3 quarters · filed 2019-03-15 | -$1.96M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | -$152.00K 10-Q · filed 2018-05-09 | -$421.00K derived: sum of 2 quarters · filed 2019-03-15 | -$1.90M derived: sum of 3 quarters · filed 2019-03-15 | -$1.57M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | -$269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$1.75M derived: sum of 2 quarters · filed 2019-03-15 | -$1.42M derived: sum of 3 quarters · filed 2019-03-15 | -$610.00K 10-K · filed 2019-03-15 |
| 2016-09-30 | -$1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$1.15M derived: sum of 2 quarters · filed 2017-11-07 | -$341.00K 10-Q · filed 2017-11-07 | -$76.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $332.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $1.14M 10-Q · filed 2017-08-11 | $1.40M derived: sum of 3 quarters · filed 2018-03-15 | $1.44M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $805.00K 10-Q · filed 2017-05-11 | $1.07M derived: sum of 2 quarters · filed 2018-03-15 | $1.11M derived: sum of 3 quarters · filed 2018-03-15 | |
| 2015-12-31 | $265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $306.00K derived: sum of 2 quarters · filed 2018-03-15 | $153.00K 10-K · filed 2018-03-15 | |
| 2015-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$112.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$153.00K 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $514.00K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |